MST develops image‑guided surgical systems built on a proprietary image analytic technology platform; its flagship product is AutoLap®, an FDA‑cleared and CE‑approved image‑guided laparoscope positioning system. AutoLap® offers surgeons hands‑free, natural control of laparoscopic procedures with minimal user interaction and is aimed at the large minimally invasive surgery market. The company says healthcare providers benefit from cost‑effective technology that can enable more efficient procedures. MST is privately held, was founded in 2005, and is based in Yokneam, Israel. Management plans to use the recent investment primarily to expand marketing and sales of AutoLap® in the U.S., Europe and China. As part of the deal, the lead investor Haisco will serve as AutoLap®’s exclusive distributor in China.

Total raised

$13M

Funding rounds

1

Latest round

Series C

Latest activity

Jul 2015